A Safety Study of Eptifibatide in Patients With Sickle Cell Disease
Clinical trial NCT00834899 · TERMINATED
Trial details
- NCT number
- NCT00834899
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2012-03-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.